Tag: Prescription Drugs
Adding Pembrolizumab to Chemo Improves Survival in Endometrial Cancer
Addition of pembrolizumab to paclitaxel plus carboplatin yields longer progression-free survival in advanced, recurrent disease
Adding Dostarlimab Improves Progression-Free Survival in Endometrial Cancer
Dostarlimab plus carboplatin-paclitaxel linked to increased progression-free survival overall and in dMMR-MSI-H population
Thorough Medication History in ED Cuts Med Discrepancy Rates
Lowest discrepancy rates experienced by patients who received best possible medication history in emergency department and discharge medication reconciliation
CDC: 2016 to 2021 Saw Increase in Adults Receiving Stimulant Prescriptions
During 2020 to 2021, more than 10 percent increase seen in percentage of women aged 15 to 44 years, men aged 25 to 44 years with prescription fills
Fitusiran Beneficial in Hemophilia A, B With or Without Inhibitors
Reduction in annualized bleeding rate seen compared with bypassing agents on demand and on-demand clotting factor concentrates
AAD: Promising Results Seen for Bimekizumab in Hidradenitis Suppurativa
Significantly higher proportion of hidradenitis suppurativa patients treated with bimekizumab achieved primary end point of HiSCR50
AAD: Long-Term Improvement Seen With Ruxolitinib in Vitiligo
Improvement in facial/total Vitiligo Area Scoring Index seen with continued treatment from weeks 52 to 104
Hydroxyurea Underused in Youth With Sickle Cell
Majority of youth in Michigan and New York with sickle cell anemia did not have filled hydroxyurea prescriptions
Higher Risk for CRC Seen in Adults Exposed to Bendectin In Utero
Risk of colorectal cancer higher in offspring exposed in utero during 1960s versus unexposed offspring
Nirmatrelvir Cuts Risk for Post-COVID-19 Condition
Findings seen regardless of vaccination status and history of prior infection
